Status:
COMPLETED
A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil
Lead Sponsor:
Cynthia S Firnhaber
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV
HIV Infections
Eligibility:
FEMALE
18+ years
Brief Summary
This is a study to determine what Human Papillomavirus HIV seropositive women in Botswana, South Africa and Brasil have been exposed to during their life. The Human Papillomavirus causes cervical canc...
Detailed Description
Plasma from HIV seropositive women will be taken and sent to MERCK in the USA to evaluate what the antibody titers of HPV 6,11,16 and 18. .
Eligibility Criteria
Inclusion
- HIV seropositive women 18 years of age and older Consent signed per local IRB requirement
Exclusion
- Can not give blood
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
487 Patients enrolled
Trial Details
Trial ID
NCT00840905
Start Date
February 1 2009
End Date
December 1 2010
Last Update
November 7 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Shahin Lockman
Habarone, Botswana
2
Fundacao Oswaldo Cruz
Rio de Janeiro, Brazil
3
University of Witwatersrand/Helen Joseph Hospital
Johannesburg, South Africa